Cardinal Health, Inc.
NYSE:CAHMedical - Distribution
-$3.77 today
- Market cap
- $64.33B
- Beta
- 0.53
- P/E (TTM)
- 33.5
- EPS (TTM)
- $6.63
- Dividend yield
- 0.92%
Volume 1.35M
Average 2.11M
CAH Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Cardinal Health, Inc.NYSE: CAH
Financing Cash Flow · Q1 FY2027 · quarter ended Sep 2026
Financing cash flow growth accelerates
Q1 FY2027 financing cash flow of $742M (cash outflow) rose 574.5% year over year, ahead of the -193.8% change in trailing-twelve-month financing cash flow. Sequentially, it rose 51.4% from the prior quarter. Over 3 fiscal years it compounded at -19.3% a year.
Context
- Financing cash flow amounted to 0.6% of revenue in FY2026, down 0.2 pp from a year earlier.
- Financing cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +574.5% holds above the trailing-twelve-month pace of -193.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2026
- (1.6B) USD
- Year-over-year change
- -182.1%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | (1.6B) | -182.1% |
| FY2025 | 2025-06-30 | 1.95B | +330.5% |
| FY2024 | 2024-06-30 | (847M) | +72.2% |
| FY2023 | 2023-06-30 | (3.05B) | -23.9% |
| FY2022 | 2022-06-30 | (2.46B) | — |
Financing Cash Flow vs competitors
How CAH compares with its peers on the latest reported figures
- CAH's LTM Sep 2026 financing cash flow of $2.23B is the 2nd largest of the 4 companies compared; the peer median is $381M.
- Its year-over-year change of -193.8% is the lowest of 4, against a peer median of +110.9%.
- Financing cash flow amounts to 0.9% of revenue for CAH, versus a peer median of 1.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $4.18B | +110.9% | +2.0% | 1.0% | |
| LTM Sep 2026 | $2.23B | -193.8% | -19.3% | 0.9% | |
| LTM Jun 2026 | $1.57B | -20.5% | — | 0.5% | |
| LTM Jun 2026 | $381M | +632.7% | -29.4% | 2.8% | |
| Peer median (excluding CAH) | $381M | +110.9% | -13.7% | 1.0% | |
Competitors are the stored peer set for CAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Net Income | (933M) | 331M | 853M | 1.57B | 1.71B |
| Depreciation & Amortization | 692M | 692M | 710M | 790M | 956M |
| Deferred Income Tax | 7M | (40M) | (104M) | 243M | 91M |
| Stock-Based Compensation | 0 | 96M | 121M | 244M | 367M |
| Change in Working Capital | 1.12B | 457M | 1.51B | (523M) | 2.09B |
| Accounts Receivables | (1.53B) | (950M) | (996M) | (833M) | (408M) |
| Inventory | (1.07B) | (412M) | 1.12B | (1.82B) | (488M) |
| Accounts Payables | 3.43B | 2.82B | 1.82B | 2.73B | 3.46B |
| Other Working Capital | 293M | (997M) | (433M) | (606M) | (481M) |
| Other Non-Cash Items | 2.23B | 1.31B | 672M | 74M | (31M) |
| Operating Cash Flow | 3.12B | 2.84B | 3.76B | 2.4B | 5.17B |
| Capital Expenditures | (387M) | (481M) | (511M) | (547M) | (649M) |
| Acquisitions (Net) | 901M | (10M) | (1.19B) | (5.25B) | (1.99B) |
| Purchases of Investments | (78M) | 0 | (550M) | 0 | 0 |
| Sales of Investments | 100M | 29M | 384M | 202M | 41M |
| Other Investing Activities | 31M | 8M | 18M | (10M) | 15M |
| Investing Cash Flow | 567M | (454M) | (1.85B) | (5.61B) | (2.58B) |
| Debt Repayment | (885M) | (579M) | 356M | 3.22B | 337M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (1B) | (2B) | (750M) | (765M) | (1.36B) |
| Dividends Paid | (559M) | (525M) | (499M) | (494M) | (491M) |
| Other Financing Activities | (19M) | 53M | 46M | (13M) | (90M) |
| Financing Cash Flow | (2.46B) | (3.05B) | (847M) | 1.95B | (1.6B) |
| Effect of Forex Changes | 84M | (8M) | (9M) | (3M) | (6M) |
| Net Change in Cash | 1.31B | (669M) | 1.06B | (1.26B) | 982M |
| Free Cash Flow | 2.74B | 2.36B | 3.25B | 1.85B | 4.53B |
Cardinal Health, Inc.
NYSE:CAH
Intrinsic Alpha fair value
Locked
Current Price
$278.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.